K

KeyMed Biosciences Inc
HKEX:2162

Watchlist Manager
KeyMed Biosciences Inc
HKEX:2162
Watchlist
Price: 43.7 HKD -2.35%
Market Cap: 12B HKD
Have any thoughts about
KeyMed Biosciences Inc?
Write Note

Wall Street
Price Targets

Price Targets Summary
KeyMed Biosciences Inc

Wall Street analysts forecast KeyMed Biosciences Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KeyMed Biosciences Inc is 60.79 HKD with a low forecast of 50.5 HKD and a high forecast of 75.6 HKD.

Lowest
Price Target
50.5 HKD
16% Upside
Average
Price Target
60.79 HKD
39% Upside
Highest
Price Target
75.6 HKD
73% Upside
KeyMed Biosciences Inc Competitors:
Price Targets
TNGX
Tango Therapeutics Inc
391% Upside
301047
Sino Biological Inc
44% Upside
MDGL
Madrigal Pharmaceuticals Inc
9% Upside
IMAB
I-Mab
550% Upside
300685
Amoy Diagnostics Co Ltd
2% Upside
CDMO
Avid Bioservices Inc
13% Upside
002007
Hualan Biological Engineering Inc
29% Upside
000403
Pacific Shuanglin Bio pharmacy Co Ltd
41% Upside

Revenue
Forecast

Revenue Estimate
KeyMed Biosciences Inc

The compound annual growth rate of KeyMed Biosciences Inc's revenue for the next 3 years is 58%.

N/A
Past Growth
58%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
KeyMed Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
KeyMed Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KeyMed Biosciences Inc's stock price target?
Price Target
60.79 HKD

According to Wall Street analysts, the average 1-year price target for KeyMed Biosciences Inc is 60.79 HKD with a low forecast of 50.5 HKD and a high forecast of 75.6 HKD.

What is KeyMed Biosciences Inc's Revenue forecast?
Projected CAGR
58%

The compound annual growth rate of KeyMed Biosciences Inc's revenue for the next 3 years is 58%.

Back to Top